IP Library Assignment 035125/0164
Patent Assignment
Reel/Frame 035125/0164

Change of Name

Recorded: 2015-03-04 Pages: 4
Assignor
N30 PHARMACEUTICALS, INC.
Executed: 2015-02-11
Assignee
NIVALIS THERAPEUTICS, INC.
3122 STERLING CIRLCE, BOULDER, COLORADO, 80301
Covered Properties (33)
Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors
Patent: 9,249,132 →
Application: 13/991,973 →
Publication: US 2013/0261122
Compounds as S-Nitrosoglutathione Reductase Inhibitors
Application: 14/123,220 →
Publication: US 2014/0094465
Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents for Liver Toxicity
Application: 14/126,468 →
Publication: US 2014/0113945
Pyrrole Inhibitors of S-Nitrosoglutathione Reductase
Patent: 9,029,402 →
Application: 14/146,089 →
Publication: US 2014/0113938
Chromone Inhibitors of S-Nitrosoglutathione Reductase
Application: 14/168,595 →
Publication: US 2014/0163092
Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents
Patent: 9,138,427 →
Application: 14/204,849 →
Publication: US 2014/0194425
Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors
Patent: 9,067,893 →
Application: 14/262,915 →
Publication: US 2014/0235640
Novel S-Nitrosoglutathione Reductase Inhibitors
Patent: 9,187,447 →
Application: 14/291,709 →
Publication: US 2014/0275185
Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors
Patent: 9,012,646 →
Application: 14/326,686 →
Publication: US 2014/0329821
Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors
Patent: 9,139,528 →
Application: 14/540,216 →
Publication: US 2015/0080429
Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents
Patent: 9,180,119 →
Application: 14/598,062 →
Publication: US 2015/0126570
Novel Dihydropyridin-2(1H)-One Compounds as S-Nitrosoglutathione Reductase Inhibitors and Neurokinin-3 Receptor Antagonists
Patent: 9,283,213 →
Application: 14/598,202 →
Publication: US 2015/0157616
Novel Compounds for the Treatment of Cystic Fibrosis
Application: 61/968,668 →
Methods for the Treatment of Cystic Fibrosis
Application: 62/061,557 →
Methods for the Treatment of Cystic Fibrosis
Application: 62/093,712 →
Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents
Patent: 8,691,816 →
Application: 13/057,171 →
Publication: US 2011/0144110
Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents
Patent: 8,470,857 →
Application: 13/057,173 →
Publication: US 2011/0136881
Pyrrole Inhibitors of S-Nitrosoglutathione Reductase
Patent: 8,642,628 →
Application: 13/057,175 →
Publication: US 2011/0136875
Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents
Patent: 8,673,961 →
Application: 13/057,220 →
Publication: US 2011/0144180
Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors
Patent: 8,741,915 →
Application: 13/496,799 →
Publication: US 2012/0208817
Novel Thiophene Inhibitors of S-Nitrosoglutathione Reductase
Patent: 8,586,624 →
Application: 13/513,864 →
Publication: US 2012/0245210
Chromone Inhibitors of S-Nitrosoglutathione Reductase
Patent: 8,481,590 →
Application: 13/521,820 →
Publication: US 2012/0295966
Novel S-Nitrosoglutathione Reductase Inhibitors
Patent: 8,759,548 →
Application: 13/521,833 →
Publication: US 2012/0289555
Novel Dihydropyridin-2(1H)-One Compounds as S-Nitrosoglutathione Reductase Inhibitors and Neurokinin-3 Receptor Antagonists
Patent: 8,946,434 →
Application: 13/805,626 →
Publication: US 2013/0096161
Novel Dihydropyrimidin-2(1H)-One Compounds as Neurokinin-3 Receptor Antagonists
Patent: 8,906,933 →
Application: 13/814,316 →
Publication: US 2013/0131093
Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors
Patent: 8,921,562 →
Application: 13/824,430 →
Publication: US 2013/0178499
Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents
Patent: 8,686,015 →
Application: 13/901,660 →
Publication: US 2013/0253024
Chromone Inhibitors of S-Nitrosoglutathione Reductase
Patent: 8,669,381 →
Application: 13/912,287 →
Publication: US 2013/0274320
Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors
Patent: 8,785,643 →
Application: 13/991,972 →
Publication: US 2013/0261123
Novel Thiophene Inhibitors of S-Nitrosoglutathione Reductase
Patent: 8,859,611 →
Application: 14/071,848 →
Publication: US 2014/0057957
Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents
Patent: 8,957,105 →
Application: 14/173,377 →
Publication: US 2014/0155447
Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents
Patent: 8,846,736 →
Application: 14/204,875 →
Publication: US 2014/0194481
Novel Compounds for the Treatment of Cystic Fibrosis
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 2, 2011
From: WASLEY, JAN; ROSENTHAL, GARY J.; SUN, XICHENG; STRONG, SARAH
To: N30 PHARMACEUTICALS, LLC
Reel/Frame 025735/0334 →
Assignment of Assignor's Interest Feb 2, 2011
From: WASLEY, JAN; ROSENTHAL, GARY J.; SUN, XICHENG; STRONG, SARAH
To: N30 PHARMACEUTICALS, LLC
Reel/Frame 025735/0107 →
Assignment of Assignor's Interest Feb 2, 2011
From: WASLEY, JAN; ROSENTHAL, GARY J.; SUN, XICHENG; STRONG, SARAH
To: N30 PHARMACEUTICALS, LLC
Reel/Frame 025734/0988 →
Assignment of Assignor's Interest Feb 2, 2011
From: WASLEY, JAN; ROSENTHAL, GARY J.; SUN, XICHENG; STRONG, SARAH
To: N30 PHARMACEUTICALS, LLC
Reel/Frame 025734/0960 →
Assignment of Assignor's Interest Mar 19, 2012
From: SUN, XICHENG; QIU, JIAN
To: N30 PHARMACEUTICALS, LLC
Reel/Frame 027884/0130 →
Conversion of N30 Pharmaceuticals, Llc from a Delaware Limited Liability Company to a Delaware Corporation Under the Name of N30 Pharmaceuticals, Inc. Aug 10, 2012
From: N30 PHARMACEUTICALS, LLC
To: N30 PHARMACEUTICALS, INC.
Reel/Frame 028769/0496 →
Change of Name Jun 7, 2013
From: N30 PHARMACEUTICALS, LLC
To: N30 PHARMACEUTICALS, INC.
Reel/Frame 030574/0940 →
Assignment of Assignor's Interest Jun 7, 2013
From: SUN, XICHENG; QIU, JIAN; STOUT, ADAM
To: N30 PHARMACEUTICALS, LLC
Reel/Frame 030564/0376 →
Change of Name Dec 1, 2013
From: N30 PHARMACEUTICALS, LLC
To: N30 PHARMACEUTICALS, INC.
Reel/Frame 031745/0356 →
Assignment of Assignor's Interest Dec 1, 2013
From: SUN, XICHENG; QIU, JIAN; STOUT, ADAM
To: N30 PHARMACEUTICALS, LLC
Reel/Frame 031695/0128 →
Change of Name Jan 1, 2014
From: N30 PHARMACEUTICALS, LLC
To: N30 PHARMACEUTICALS, INC.
Reel/Frame 031896/0484 →
Assignment of Assignor's Interest Jan 1, 2014
From: ROSENTHAL, GARY J.; SCOGGIN, CHARLES H.; COLAGIOVANNI, DOROTHY
To: N30 PHARMACEUTICALS, LLC
Reel/Frame 031875/0122 →
Assignment of Assignor's Interest Jan 2, 2014
From: WASLEY, JAN; ROSENTHAL, GARY J.; SUN, XICHENG; STRONG, SARAH
To: N30 PHARMACEUTICALS, LLC
Reel/Frame 031882/0757 →
Change of Name Jan 2, 2014
From: N30 PHARMACEUTICALS, LLC
To: N30 PHARMACEUTICALS, INC.
Reel/Frame 031911/0668 →
Change of Name Jan 30, 2014
From: N30 PHARMACEUTICALS, LLC
To: N30 PHARMACEUTICALS, INC.
Reel/Frame 032144/0759 →
Assignment of Assignor's Interest Jan 30, 2014
From: SUN, XICHENG; QIU, JIAN; WASLEY, JAN
To: N30 PHARMACEUTICALS, LLC
Reel/Frame 032096/0406 →
Change of Name Mar 12, 2014
From: N30 PHARMACEUTICALS, L.L.C.
To: N30 PHARMACEUTICALS, INC.
Reel/Frame 032436/0545 →
Assignment of Assignor's Interest Mar 12, 2014
From: WASLEY, JAN; ROSENTHAL, GARY J.; SUN, XICHENG; STRONG, SARAH
To: N30 PHARMACEUTICALS, L.L.C.
Reel/Frame 032414/0906 →
Change of Name Apr 29, 2014
From: N30 PHARMACEUTICALS, LLC
To: N30 PHARMACEUTICALS, INC.
Reel/Frame 032784/0313 →
Assignment of Assignor's Interest Apr 29, 2014
From: SUN, XICHENG; QIU, JIAN
To: N30 PHARMACEUTICALS, LLC
Reel/Frame 032778/0548 →
Assignment of Assignor's Interest May 30, 2014
From: SUN, XICHENG; QIU, JIAN
To: N30 PHARMACEUTICALS, LLC
Reel/Frame 032999/0297 →
Change of Name May 30, 2014
From: N30 PHARMACEUTICALS, LLC
To: N30 PHARMACEUTICALS, INC.
Reel/Frame 033071/0852 →
Assignment of Assignor's Interest Jul 9, 2014
From: SUN, XICHENG; QIU, JIAN; STOUT, ADAM
To: N30 PHARMACEUTICALS, LLC
Reel/Frame 033271/0763 →
Change of Name Jul 9, 2014
From: N30 PHARMACEUTICALS, LLC
To: N30 PHARMACEUTICALS, INC.
Reel/Frame 033282/0788 →
Assignment of Assignor's Interest Oct 30, 2014
From: GABRIEL, SHERIF; BOVE, PETER
To: N30 PHARMACEUTICALS, INC.
Reel/Frame 034070/0789 →